Clinical Trial Update: A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates a long-term study of spesolimab in hidradenitis suppurativa has been terminated (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• SPESOLIMAB (BI655130)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hidradenitis Suppurativa (HS) | Phase 2, Phase 3 | Status: TERMINATED